Shanti Inorganics Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | 🔥 130.97x | 1,081,600 | 141,654,400 | ₹9 Cr |
| NII (HNI) | 🔥 195.53x | 811,200 | 158,616,000 | ₹7 Cr |
| Retail | 🔥 125.72x | 1,894,400 | 238,160,000 | ₹16 Cr |
| Market Maker | — | 284,800 | — | ₹2 Cr |
| Σ Total | 🔥 142.17x | 3,787,200 | 538,430,400 | ₹31 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹132,800 |
| Retail (Max) | 13 | 20,800 | ₹1,726,400 |
| S-HNI (Min) | 14 | 22,400 | ₹1,859,200 |
| B-HNI (Min) | 67 | 107,200 | ₹8,897,600 |
Financial Statements Amount in ₹ Crore
| Metric | 31 May 2026 | 31 Mar 2026 | 31 Mar 2025 |
|---|---|---|---|
| Revenue | 16 | 73 | 58 |
| EBITDA | 4 | 15 | 12 |
| Profit After Tax | 3 | 10 | 8 |
| Net Worth | 51 | 48 | 26 |
| Total Assets | 111 | 97 | 66 |
| Reserves & Surplus | 39 | 37 | 25 |
| Total Borrowing | — | — | 25 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Part funding the capital expenditure towards setting up a new facility for manufacturing of sodium meta bisulphite, sodium bisulphite powder and ammonium bisulphite situated at Bavla, Ahmedabad, Gujarat; – 43.00
- General Corporate Purposes –
Company Overview
Incorporated in January 2010, Shanti Inorganics Ltd. manufactures and trades sulfur-based inorganic chemicals. Its main products include sodium metabisulphite, sodium sulfite powder, ammonium bisulfite solution, and sodium bisulfite powder/solution.
These products are mainly used as preservatives, reducing agents, oxygen scavengers, and process intermediates across industries such as oil drilling, pharmaceuticals, food and beverages, pulp and paper, and water treatment.
The company operates two manufacturing facilities in Gujarat: one at GIDC, Vatva, Ahmedabad, and the other at Sankalp Industrial Estate, Chiyada, Bavla, Ahmedabad.
The company sells its products in both domestic and international markets. In the domestic market, it served 29 customers during the two-month period ended May 31, 2026, compared with 64 customers in Fiscal 2026, 48 in Fiscal 2025, and 46 in Fiscal 2024. In international markets, it served 8 customers during the two-month period ended May 31, 2026, compared with 20 customers in Fiscal 2026 and 21 customers each in Fiscal 2025 and Fiscal 2024.
The company exports its products to several countries, including the United Arab Emirates, Malaysia, Qatar, Nigeria, Russia, Colombia, Turkey, Vietnam, Egypt, Ghana, the Philippines, and others.
As of May 31, 2026, the company had 66 employees across various departments.
Key Strengths
- Growing international presence: The company sells its products in several overseas markets, reducing its dependence on the domestic market.
- Diversified customer base: It has established relationships with customers across multiple industries, which helps reduce dependence on any single sector.
- Strategic manufacturing locations: Its production facilities are located in Gujarat, providing access to raw materials and established supplier relationships.
- Quality and safety standards: The company follows relevant quality and food safety standards and holds certifications supporting its manufacturing and product quality.